文献速递胃肠外科

机器人与腹腔镜胃切除术治疗胃癌的短期及三年肿瘤学结局比较:一项大型多中心队列研究

Comparison of Short-term and Three-year Oncological Outcomes Between Robotic and Laparoscopic Gastrectomy for Gastric Cancer: A Large Multicenter Cohort Study.
PubMed 文献 · Ann Surg · 2024-01-24

这项回顾性队列研究纳入中国8家高容量医院2015年1月至2019年6月接受根治性胃切除术的3599例胃癌患者,经倾向性评分匹配后比较机器人胃切除术(RG)与腹腔镜胃切除术(LG)的短期及三年肿瘤学结局。匹配后共1034对患者,RG与LG的3年无病生存率分别为83.7%和83.1%(P=0.745),3年总生存率分别为85.2%和84.4%(P=0.647),复发累积发生率均为15.0%(P=0.988)。作者结论认为,对于可切除胃癌包括进展期病例,由经验丰富的外科医生实施时RG是安全术式,其3年肿瘤学结局与LG相当。

要点

  • 匹配后RG与LG的3年无病生存率为83.7% vs 83.1%(P=0.745),无显著差异。
  • RG与LG的3年总生存率为85.2% vs 84.4%(P=0.647),无显著差异。
  • RG术中失血量更少、中转率更低、住院时间更短(均P>0.05)。

核心结论

  • 对于可切除胃癌包括进展期病例,由经验丰富的外科医生实施时RG是安全术式,其3年肿瘤学结局与LG相当。

研究设计与样本

  • 回顾性队列研究,纳入中国8家高容量医院2015年1月至2019年6月接受根治性胃切除术的3599例胃癌患者。
  • 对接受RG与LG的患者进行倾向性评分匹配,主要终点为3年无病生存率(DFS)。

主要发现

  • 1:1倾向性评分匹配后,1034对患者纳入平衡队列进一步分析。
  • RG与LG的3年DFS分别为83.7%和83.1%(P=0.745),3年总生存率分别为85.2%和84.4%(P=0.647)。
  • 3年随访期间,RG与LG组分别有154例患者复发,复发累积发生率均为15.0%(P=0.988)。
  • 两组复发部位无显著差异(均P>0.05)。
  • 敏感性分析显示,在进展期(病理T2-4a)患者中,RG与LG的3年DFS分别为77.4%和76.7%(P=0.745),总生存率分别为79.7%和78.4%(P=0.577),3年内复发模式亦相似(均P>0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the short-term and long-term outcomes between robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) for gastric cancer. BACKGROUND: The clinical outcomes of RG over LG have not yet been effectively demonstrated. METHODS: This retrospective cohort study included 3599 patients with gastric cancer who underwent radical gastrectomy at eight high-volume hospitals in China from January 2015 to June 2019. Propensity score matching was performed between patients who received RG and LG. The primary end point was 3-year disease-free survival (DFS). RESULTS: After 1:1 propensity score matching, 1034 pairs of patients were enrolled in a balanced cohort for further analysis. The 3-year DFS in the RG and LG was 83.7% and 83.1% ( P =0.745), respectively, and the 3-year overall survival was 85.2% and 84.4%, respectively ( P =0.647). During 3 years of follow-up, 154 patients in the RG and LG groups relapsed (cumulative incidence of recurrence: 15.0% vs 15.0%, P =0.988). There was no significant difference in the recurrence sites between the 2 groups (all P >0.05). Sensitivity analysis showed that RG had comparable 3-year DFS (77.4% vs 76.7%, P =0.745) and overall survival (79.7% vs 78.4%, P =0.577) to LG in patients with advanced (pathologic T2-4a) disease, and the recurrence pattern within 3 years was also similar between the 2 groups (all P >0.05). RG had less intraoperative blood loss, lower conversion rate, and shorter hospital stays than LG (all P >0.05). CONCLUSIONS: For resectable gastric cancer, including advanced cases, RG is a safe approach with comparable 3-year oncological outcomes to LG when performed by experienced surgeons.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Lu J, Li TY, Zhang L, et al. Comparison of Short-term and Three-year Oncological Outcomes Between Robotic and Laparoscopic Gastrectomy for Gastric Cancer: A Large Multicenter Cohort Study. Ann Surg. 2024. PMID: 38264902. doi:10.1097/SLA.0000000000006215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。